The reiteration of an Overweight rating and maintenance of a $170 price target by a reputable analyst firm like Stephens & Co. could instill confidence among investors about Illumina's future prospects. This endorsement is likely to have a positive short-term impact on Illumina's stock price as it reaffirms the company's strong position in the market according to the analyst's view.